Condition (MeSH)
Intracranial Hemorrhage, Hypertensive
ClinicalTrials.gov lists 23 trials for Intracranial Hemorrhage, Hypertensive or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Intracranial Hemorrhage, Hypertensive itself; the rest are tagged with a narrower condition beneath it.
When did Intracranial Hemorrhage, Hypertensive trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 4 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 2 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Intracranial Hemorrhage, Hypertensive trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 3 |
| Not applicable | 9 |
| Observational | 6 |
How many Intracranial Hemorrhage, Hypertensive trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Enrolling by invitation | 1 |
| Completed | 7 |
| Suspended | 1 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Standard management | 2 |
| Open-label Fingolimod | 1 |
| AICH-PXZY | 1 |
| Urapidil and Esmolol | 1 |
| Yiqi Huayu Jiedu Mixture Intervention | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Intracranial Hemorrhage, Hypertensive trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Infection | 7 | 1 |
| Cardiac event | 3 | 1 |
Which publications cover Intracranial Hemorrhage, Hypertensive? (17)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Minimally invasive surgeries for spontaneous hypertensive intracerebral hemorrhage (MISICH): a multicenter randomized controlled trial. | BMC medicine | 2024 | Yes |
| Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage. | Stroke | 2019 | Yes |
| Comparison of endoscopic evacuation, stereotactic aspiration and craniotomy for the treatment of supratentorial hypertensive intracerebral haemorrhage: study protocol for a randomised controlled trial. | Trials | 2017 | Yes |
| Intractable Central Hyperthermia in the Setting of Brainstem Hemorrhage. | Therapeutic hypothermia and temperature management | 2016 | Yes |
| Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial. | Chinese journal of integrative medicine | 2016 | Yes |
Showing 5 of 17 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.